Kelyniam Global (OTC:KLYG) Stock, Quote.Headers.trade-ideas

Kelyniam Global Inc engaged in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures.

News

KLYG

KLYG Receives FDA Clearance To Market Cranial Implant (KLYG)

KELYNIAM GLOBAL INC by Kelyniam Global, Inc.

Kelyniam Global Inc

<p>Kelyniam Global (KLYG) an emerging medical device manufacturer, announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Patient Specific Custom Cranial Implants.  </p>

Earnings

Small Cap

Press Releases

Strong Fourth Quarter Powers 2023 Kelyniam Financials

NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use

Kelyniam Global Releases Q1 Financials

Kelyniam Global Releases Strong Q2 Financials

Kelyniam Global Releases Q3 Financials, Strong Performance Continues

Offerings

Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering

Short Sellers

Kelyniam Corporate Update

Kelyniam Global

Comments

Kelyniam Global

Kelyniam Global (OTC:KLYG) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga